This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Albireo Pharma Beheer
Beheer criteriumcontroles 2/4
Belangrijke informatie
Ron Cooper
Algemeen directeur
US$6.0m
Totale compensatie
Percentage CEO-salaris | 9.8% |
Dienstverband CEO | 7.7yrs |
Eigendom CEO | 0.2% |
Management gemiddelde ambtstermijn | 4.2yrs |
Gemiddelde ambtstermijn bestuur | 5.5yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$131m |
Jun 30 2022 | n/a | n/a | -US$36m |
Mar 31 2022 | n/a | n/a | -US$33m |
Dec 31 2021 | US$6m | US$590k | -US$34m |
Sep 30 2021 | n/a | n/a | -US$48m |
Jun 30 2021 | n/a | n/a | -US$136m |
Mar 31 2021 | n/a | n/a | -US$120m |
Dec 31 2020 | US$3m | US$570k | -US$108m |
Sep 30 2020 | n/a | n/a | -US$90m |
Jun 30 2020 | n/a | n/a | -US$82m |
Mar 31 2020 | n/a | n/a | -US$78m |
Dec 31 2019 | US$3m | US$551k | -US$63m |
Sep 30 2019 | n/a | n/a | -US$71m |
Jun 30 2019 | n/a | n/a | -US$63m |
Mar 31 2019 | n/a | n/a | -US$61m |
Dec 31 2018 | US$4m | US$530k | -US$46m |
Sep 30 2018 | n/a | n/a | -US$35m |
Jun 30 2018 | n/a | n/a | -US$28m |
Mar 31 2018 | n/a | n/a | -US$19m |
Dec 31 2017 | US$2m | US$460k | -US$24m |
Sep 30 2017 | n/a | n/a | -US$31m |
Jun 30 2017 | n/a | n/a | -US$28m |
Mar 31 2017 | n/a | n/a | -US$20m |
Dec 31 2016 | US$4m | US$400k | -US$16m |
Compensatie versus markt: Ron's total compensation ($USD6.04M) is above average for companies of similar size in the German market ($USD1.12M).
Compensatie versus inkomsten: Ron's compensation has increased whilst the company is unprofitable.
CEO
Ron Cooper (59 yo)
7.7yrs
Tenure
US$6,041,334
Compensatie
Mr. Ronald H. W. Cooper, also known as Ron, serves as Independent Director at Generation Bio Co. since March 2021. He has been the Chief Executive Officer and President of Albireo Pharma Inc. since July 20...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, President & Director | 7.7yrs | US$6.04m | 0.16% € 1.4m | |
CFO & Treasurer | 4.4yrs | US$1.71m | 0.066% € 572.3k | |
Chief Regulatory Officer | 6.3yrs | US$1.73m | 0.018% € 152.3k | |
Co-Founder & VP of Development | no data | geen gegevens | geen gegevens | |
Chief Scientific Officer | 15.2yrs | US$1.40m | 0.17% € 1.5m | |
Chief Technology Officer | 1.9yrs | geen gegevens | geen gegevens | |
Chief Legal Officer | 4.8yrs | geen gegevens | 0.016% € 137.3k | |
Chief Human Resources Officer | 3.3yrs | geen gegevens | 0.027% € 230.9k | |
VP & Global Project Head | no data | geen gegevens | geen gegevens | |
Chief Commercial Officer | 4yrs | US$1.96m | 0.11% € 926.5k | |
Chief Business Officer | 1.3yrs | geen gegevens | geen gegevens | |
Chief Medical Officer | less than a year | geen gegevens | geen gegevens |
4.2yrs
Gemiddelde duur
58.5yo
Gemiddelde leeftijd
Ervaren management: BDQM's management team is considered experienced (4.2 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, President & Director | 7.5yrs | US$6.04m | 0.16% € 1.4m | |
Independent Chairman of the Board | 15.1yrs | US$282.44k | 0.27% € 2.3m | |
Independent Director | 6.3yrs | US$266.82k | 0.14% € 1.3m | |
Independent Director | 7.4yrs | US$264.94k | 0.13% € 1.1m | |
Director | less than a year | geen gegevens | geen gegevens | |
Independent Director | less than a year | geen gegevens | geen gegevens | |
Independent Director | 4.8yrs | US$249.94k | 0.14% € 1.2m | |
Director | less than a year | geen gegevens | geen gegevens |
5.5yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren bestuur: BDQM's board of directors are considered experienced (5.5 years average tenure).